Prospective Accuracy for Longitudinal Markers

In this article we focus on appropriate statistical methods for characterizing the prognostic value of a longitudinal clinical marker. Frequently it is possible to obtain repeated measurements. If the measurement has the ability to signify a pending change in the clinical status of a patient then the marker has the potential to guide key medical decisions. Heagerty, Lumley, and Pepe (2000, Biometrics 56, 337-344) proposed characterizing the diagnostic accuracy of a marker measured at baseline by calculating receiver operating characteristic curves for cumulative disease or death incidence by time t. They considered disease status as a function of time, D(t) = 1(T<or=t), for a clinical event time T. In this article we aim to address the question of how well Y(s), a diagnostic marker measured at time s(s>or= 0, after the baseline time) can discriminate between people who become diseased and those who do not in a subsequent time interval [s, t]. We assume the disease status is derived from an observed event time T and thus interest is in individuals who transition from disease free to diseased. We seek methods that also allow the inclusion of prognostic covariates that permit patient-specific decision guidelines when forecasting a future change in health status. Our proposal is to use flexible semiparametric models to characterize the bivariate distribution of the event time and marker values at an arbitrary time s. We illustrate the new methods by analyzing a well-known data set from HIV research, the Multicenter AIDS Cohort Study data.

[1]  Daniel O. Scharfstein,et al.  Analysis of longitudinal data with irregular, outcome‐dependent follow‐up , 2004 .

[2]  J M Taylor,et al.  Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[3]  Joseph G Ibrahim,et al.  Parameter Estimation in Longitudinal Studies with Outcome‐Dependent Follow‐Up , 2002, Biometrics.

[4]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[5]  Margaret S. Pepe,et al.  Semiparametric Receiver Operating Characteristic Analysis to Evaluate Biomarkers for Disease , 2002 .

[6]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[7]  J. Margolick,et al.  Failure of T-cell homeostasis preceding AIDS in HIV-1 infection , 1995, Nature Medicine.

[8]  M. Wulfsohn,et al.  A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.

[9]  P. Heagerty,et al.  Survival Model Predictive Accuracy and ROC Curves , 2005, Biometrics.

[10]  Yingye Zheng,et al.  Semiparametric estimation of time-dependent ROC curves for longitudinal marker data. , 2004, Biostatistics.

[11]  Yingye Zheng,et al.  Partly Conditional Survival Models for Longitudinal Data , 2005, Biometrics.

[12]  Patrick J. Heagerty,et al.  Semiparametric estimation of regression quantiles with application to standardizing weight for height and age in US children , 1999 .

[13]  J. Hanley Receiver operating characteristic (ROC) methodology: the state of the art. , 1989, Critical reviews in diagnostic imaging.

[14]  M. Wulfsohn,et al.  Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS , 1995 .

[15]  Gary Longton,et al.  Incorporating the Time Dimension in Receiver Operating Characteristic Curves: A Case Study of Prostate Cancer , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[16]  J. Phair,et al.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.

[17]  B W Turnbull,et al.  Statistical models for longitudinal biomarkers of disease onset. , 2000, Statistics in medicine.

[18]  David Couper,et al.  Modeling Partly Conditional Means with Longitudinal Data , 1997 .

[19]  D. Ransohoff Rules of evidence for cancer molecular-marker discovery and validation , 2004, Nature Reviews Cancer.

[20]  D. Rubin,et al.  Statistical Analysis with Missing Data. , 1989 .